The former administrative law judge said he had bought a "very, very large position in Arena" after he spent many hours studying the safety of lorcaserin versus other diet drugs.
The trial was stopped early in July 2011 by the data and safety monitoring board when the benefits in the Mediterranean diet groups crossed a predetermined boundary.
Perhaps it's time for New Yorkers to put their mayor on a power diet, and to wise up about the real trade-offs between expanding safety-net programs and personal choice.